Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Synovial × Idarubicin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdomyosarcoma 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Blast Crisis 1

Interventions

Doxorubicin 15 Cyclophosphamide 14 Ifosfamide 10 fludarabine 8 Radiotherapy 7 tazemetostat 5 pembrolizumab 4 Gemcitabine 4 pegfilgrastim 3 pazopanib 3 cixutumumab 3 Trabectedin 3 Imatinib Mesylate 3 Filgrastim 3 Docetaxel 3 Dacarbazine 3 sargramostim 2 fludarabine phosphate 2 brostallicin 2 aldesleukin 2 X-Rays 2 Sunitinib 2 Sorafenib 2 Radiation Dose Hypofractionation 2 Radiation 2 Interferon-gamma 2 Immunotherapy, Adoptive 2 Etoposide 2 Diathermy 2 Chemotherapy, Adjuvant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡